Aperion Biologics

📍 United States💰 Last funded Apr 2008
Biotechnology🌐 aperionbiologics.com
Website LinkedIn
Aperion Biologics has developed and patented a technique to make animal tissues usable for human applications without causing rejection. The core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both “humanizes” and sterilizes the tissues without affecting their biomechanical or biological properties. This tissue scaffold provides mechanical stability and function while being biologically integrated and remodeled. Aperion’s Z-Process™ of humanizing and sterilizing tissue can be applied to a variety of tissues from orthopaedic ligaments, bone, and meniscus to cardiovascular valves and vessels to soft tissue grafts for augmentation and repair.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Aperion Biologics?
Aperion Biologics has 1 investors on record on gritt.io.
When did Aperion Biologics last raise funding?
The most recent investment in Aperion Biologics recorded on gritt.io was in April 2008.
What industry is Aperion Biologics in?
Aperion Biologics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Aperion Biologics based?
Aperion Biologics is headquartered in United States.